HRTX Heron Therapeuti
Company Analysis
Latest News
🟢 Heron Therapeutics is trading 10% up today amid broader market gains
Heron Therapeutics is trading at $0.38, up 10.10% on October 5, 2026; market coverage linked the earlier gain to broader equities rising after...
🟢 Heron Therapeutics is trading 7.3% up today as weak payrolls ease rate-hike concerns
Heron Therapeutics is trading at $0.37, up 7.34%, amid broader rate sentiment after weak September payrolls eased rate-hike concerns and supported equities. -...
🟢 Heron Therapeutics is trading 8% up in after-hours trading as weak payrolls eased rate-hike concerns
Heron Therapeutics is trading at $0.37, up 7.83% after-hours as the weak September jobs report eased rate-hike concerns. - Reuters reported the 29,000...
🟢 Heron Therapeutics is trading 11% up on October 2, 2026, as jobs data eased rate-hike concerns
Heron Therapeutics is trading at $0.40, up 11.32%, with the move likely reflecting broader risk-on sentiment after softer-than-expected September jobs data...
🟢 Heron Therapeutics is trading 6% up today amid broader market gains
Heron Therapeutics is trading 5.84% higher at $0.38 alongside broader market gains; no direct catalyst was established. - No new company-specific announcement...
🟢 Heron Therapeutics is trading 10% up today with no clear catalyst identified
Heron Therapeutics is trading at $0.34, up 10.05% on October 1, 2026, with no clear company-specific catalyst identified. - Its investor-relations release...
🟢 Heron Therapeutics is trading 5% up today
Heron Therapeutics is trading 5.26% up at $0.33 on October 1, 2026; the reason for the gain remains unclear. - Its latest listed news release is its August 10,...
🟢 Heron Therapeutics is trading 10.5% up today
Heron Therapeutics is trading at $0.34, up 10.46%, with no specific September 30 catalyst identified. - Shares rose from the September 29 close of $0.31. - The...
🟢 Heron Therapeutics is trading 6% up
Heron Therapeutics is trading 5.69% higher at $0.32, with no clear September 30 catalyst identified. - The price is up from the September 29 close of $0.31; no...
🔴 Heron Therapeutics is trading 5% down in after-hours trading with no clear catalyst identified
Heron Therapeutics is trading 5.23% lower at $0.29 after its September 29, 2026, close at $0.31; available coverage does not establish a cause for the...
Heron Therapeutics Enters Multi-Product Development and License Agreement with Long Grove Pharmaceuticals
Heron Therapeutics, Inc. (HRTX) has entered into a multi-product Development and License Agreement with Long Grove Pharmaceuticals, LLC, effective September...
🟢 Heron Therapeutics is trading 5.5% up with no clear catalyst identified
Heron Therapeutics is trading at $0.31, up 5.52%, with no clear company-specific catalyst identified for September 29, 2026. - The available news search...
🟢 Heron Therapeutics is trading 10.33% up today
Heron Therapeutics is trading 10.33% up at $0.30 after rebounding from its September 21, 2026 close of $0.27, with no new company-specific announcement or...
🟢 Heron Therapeutics is trading 5% up today after September 21's 12.82% decline
Heron Therapeutics is trading 5.11% up at $0.28 after rebounding from the September 21, 2026 close of $0.27, when shares fell 12.82%. - No new...
🟢 Heron Therapeutics is trading 7.41% up in pre-market with no clear catalyst identified
Heron Therapeutics is trading 7.41% up now at $0.29, with no clear company-specific announcement or fresh catalyst explaining the rebound after falling 12.82%...
🔴 Heron Therapeutics is trading 15.08% down today as immediate trigger remains unclear
Heron Therapeutics is trading 15.08% down at $0.26, despite broad U.S. markets moving higher on September 21, 2026; no new company-specific announcement...
🔴 Heron Therapeutics is trading 8.01% down today with no new company-specific catalyst identified
Heron Therapeutics is trading 8.01% down at $0.28, with no clear company-specific announcement identified for September 21, 2026. - Recent reporting points to...
🔴 Heron Therapeutics is trading 5.63% down today amid generic CINVANTI entry uncertainty
Heron Therapeutics is trading 5.63% down at $0.33, amid recent competitive pressure and uncertainty surrounding potential generic CINVANTI entry. - No major...
🟢 Heron Therapeutics is trading 5.39% up today amid low-priced-stock momentum
Heron Therapeutics is trading at $0.35, up +5.39%, with the gain appearing to reflect low-priced-stock volatility and momentum after the prior session’s +5.47%...
🟢 Heron Therapeutics is trading 5.47% up in pre-market with no clear company-specific catalyst identified
Heron Therapeutics is trading 5.47% up at $0.33 in pre-market, with no clear company-specific catalyst identified for September 3, 2026. - Latest available...